An initial analysis of the FDA adverse event reporting system (FAERS) data demonstrated no consistent trends in DKA with SGLT2i use over time [39], however an alternative cohort study of 50,220 individuals with type 2 diabetes showed the highest risk of DKA shortly after SGLT2i initiation, which subsequently reduced with time [40]
Both increase the GLP-1 hormone in the body, but a GLP-1 medication is using a synthetic GLP-1 hormone to increase your levels
The medication is administered as a once-weekly subcutaneous injection and is currently in phase 3 clinical trials, with FDA approval potentially on the horizon pending trial outcomes
BPC-157 is prohibited by WADA and should not be used by athletes subject to drug testing
If you already have insurance coverage for a branded GLP-1 like Zepbound or Wegovy, that's a separate path worth comparing on cost - since Telos Rx's compounded medications are explicitly not billed to insurance
/ Some people find success taking these supplements for five days on and two days off, or taking them for a few months during high-stress seasons and then taking a break